MedTrace Logo

Regional vs General Anesthesia in Patients With Hip Fracture Under Treatment With Clopidogrel

NCT03596060 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2021-09-28

No results posted yet for this study

Summary

This study compares general to regional anesthesia concerning morbidity and mortality in patients older than or equal to 65 years old who receive clopidogrel and are to be submitted in hip fracture surgery. Half of participants will receive general anesthesia the first 48 hours and the other half will receive regional anesthesia after 5 days of the discontinuation of clopidogrel.

Conditions

  • Hip Fractures

Interventions

DRUG

Fentanyl

Fentanyl will be used for introduction in both regional and general anesthesia. It will also be used for general anesthesia maintenance.

DRUG

Propofol

Propofol will be used for introduction in general anesthesia.

DRUG

Rocuronium

Rocuronium will be used for introduction in general anesthesia.

DRUG

Chirochaine

Chirochaine 0.5% will be used in regional anesthesia.

DRUG

Morphine

Morphine will be administered bolus iv in General anesthesia group postoperatively before patients leave OR.

Sponsors & Collaborators

  • Larissa University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-20
Primary Completion
2022-05-31
Completion
2022-10-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03596060 on ClinicalTrials.gov